N
Google TrendSELMA BLAIR (2000+) — Selma Blair arrested for biting flight attendant, trying to open plane door
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:selma blair2000+al-nassr vs neftchi fergana2000+samantha busch500+peggy flanagan200+sean combs10000+boeing 747500+frank bisignano2000+justin watson500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Extended Interval Dosing" (30 stories)

Top Headline Story

Jonathan W. Goldman, MD, on SCLC: Tarlatamab Extended-Interval Dosing Regimens
Lead StoryThe ASCO Postgeneral
Oct 3

Jonathan W. Goldman, MD, on SCLC: Tarlatamab Extended-Interval Dosing Regimens

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNRUx4THJzVDNsdWZ3M3hTMDVjdS1wRWtfMENkN3NPQW9Ybm42SkVhdU45R05MRmV4bk9uNXF5YnZIb2NhbVFYdGVXRktDZ3FaX3RxTDJNekV1N1lvX3QzX0c3eWIyWXdOMDVYTjhQWkhKeF9oSjNWSXFpMW85ckVsdXFQVV9Tcm5yR2g2ZnhSNExTb3dWa1lFUHNB?oc=5" target="_blank">Jonathan W. Goldman, MD, on SCLC: Tarlatamab Extended-Interval Dosing Regimens</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
2000+32m ago

selma blair

Selma Blair arrested for biting flight attendant, trying to open plane door

Filter stories
2000+42m ago

al-nassr vs neftchi fergana

Al Nassr Asian Champions League clash in doubt over Riyadh security situation

Filter stories
500+42m ago

samantha busch

Kyle Busch’s Widow Samantha Calls His Death ‘Unfair’ After ‘Emotional’ Celebration for Beloved NASCAR Star

Filter stories
200+42m ago

peggy flanagan

Minnesota Poll: Flanagan holds narrow lead over Tafoya in U.S. Senate race

Filter stories

Search Results for "Extended Interval Dosing"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Extended Interval Dosing of Anti-CD20 Therapies: Benefits, Risks, and Real-World Experience
NeurologyLiveworld

Extended Interval Dosing of Anti-CD20 Therapies: Benefits, Risks, and Real-World Experience

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNaDlRNEtnSDRMLVQwTEg0QWoxbWcxOUVxQlV6X3RfeURsNlEtVW83SHFrektxYWY1UTYtSFI1cC1qVmZGSjZtZGVoQ2xkazd4TkZYR2N1QTBGakZJeDF1elV6YWVibkpoT1l2UVdVRnFqWVRmYkFkODhzS0F2WExlY3QtSFhBcm5nd1R4SHZBRDhpRGNxZHhEOE1OVFU1SXhCdGk2SHRPRnRKZjhWRFVVbUY5TXNkZ1VYakpzMWVycGI?oc=5" target="_blank">Extended Interval Dosing of Anti-CD20 Therapies: Benefits, Risks, and Real-World Experience</a>  <font color="#6f6f6f">NeurologyLive</font>

Read Full StoryMore like this
Extended-Interval Tarlatamab Dosing Offers Pharmacists More Flexible Administration Windows in SCLC
Pharmacy Timesgeneral

Extended-Interval Tarlatamab Dosing Offers Pharmacists More Flexible Administration Windows in SCLC

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxObG1JYUNSNGJodlE4ZHoza0tYNmdzWnhHUUlPR2cyLXBlZlBWOU84TWluMmJsY0dLSnBzNWJMYWI3eW9yeENNemdMb09jamFRNXc0OTRCbTRSYjd2VVVFcm5VWGt5bXY0X1VnYTVUbkRaVWVrUmRoM1dLNnZrdk9jN3BMSzlGS2MwXzQyU3pqdDFxY1FpZkZ5YU8zVVIwc1JoYV9PMi12SXBHWlJwT1VtTk45YmlOaUcyS0dKbkJJZ3dabHh1aDBsQVgwZDRQTEk?oc=5" target="_blank">Extended-Interval Tarlatamab Dosing Offers Pharmacists More Flexible Administration Windows in SCLC</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Extended-Interval Dosing With Zumilokibart May Redefine AD Management
Dermatology Timesgeneral

Extended-Interval Dosing With Zumilokibart May Redefine AD Management

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQN05mOVZUS0toWWhLWjVJaVhoZG1VX1Aya2ZCX3RIWUZIWEc2RjMzS3U3WjEtLWxCQWxFWFh5TE1RZ1VsWUM4NG5HMTJNUnRicDhaZkhndWhnVnpjWi1GNVV0ZHlvSkZGZ09US1FaQ0RKTHlha25Tbzk0UlhUN25HSzlJVmVDRkM3TnR1RnBBcUNVR2lhMTBFWS00SkFqUk0xSHBZV0MtVE1nQlU?oc=5" target="_blank">Extended-Interval Dosing With Zumilokibart May Redefine AD Management</a>  <font color="#6f6f6f">Dermatology Times</font>

Read Full StoryMore like this
Extended-interval tarlatamab dosing shows consistent activity and safety in previously treated small cell lung cancer
Medical Xpressworld

Extended-interval tarlatamab dosing shows consistent activity and safety in previously treated small cell lung cancer

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPTTgzTWx5eHFsVjdWb0JFYWFTQUE1azZUWmNqYm52a2Y1eFpiWTYtV05VUkxKZTdVaUtuRXVqOVJ4Sl9xT1hVWjI5U1d4U2o4LTJkVV9xaVl5NlY4a2RkVWc1Qll6N3RUWGJFUmRXZkM0cE9jbDBqUmN2REJnNVo0WThxRWNEMDNTNmtwLWc5dWJPZw?oc=5" target="_blank">Extended-interval tarlatamab dosing shows consistent activity and safety in previously treated small cell lung cancer</a>  <font color="#6f6f6f">Medical Xpress</font>

Read Full StoryMore like this
Reducing Treatment Burden in Lung Cancer With Telehealth Visits For Extended Dosing of Pembrolizumab
Cancer Nursing Todayscience

Reducing Treatment Burden in Lung Cancer With Telehealth Visits For Extended Dosing of Pembrolizumab

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxQekthM0RNWVpHS1gyaWpEajVfcWxBZlNIVWFMcklkbWZnOEpmdHZPNVp2bDdJWTh3bFBqeDVfYU1kT2dFcjFsN2lLXy01VF9iaHZVMlYwMGduU3d2T2dFMG00Vmg1UkVtMXVEd0QwR01wQnRSb2h5dlA0Tm1vUTRQN0xubE9TdEE4NFBZSS1RMTU2OGNXRUxINU1oTkMwaG0xNnUtSGFXSkl1VlBBR1hRSGYxa1JTSE9uMjZiWkdrckZyd0JHSWpjVWd4X2dvaEpud3NkTHk2SHFobTdHN0dVMFZQNlk3TmxoRVE?oc=5" target="_blank">Reducing Treatment Burden in Lung Cancer With Telehealth Visits For Extended Dosing of Pembrolizumab</a>  <font color="#6f6f6f">Cancer Nursing Today</font>

Read Full StoryMore like this
FDA approves extended dosing intervals up to 20 weeks for EYLEA HD in wAMD and DME
Ophthalmology Timesgeneral

FDA approves extended dosing intervals up to 20 weeks for EYLEA HD in wAMD and DME

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOeVNZdVBucnQ0Snh1TEw3UTc0dUk0ZGJjaUQ0ODdKUElzdHhoUTFZdnBHOU5jWktYbDlFdFlQeGxoSzVQS2NsNE5sbzdNOC1KR1hiZVlIcm1Uay1MckVtTGdNaVdIWnpZQ0NMcUhJRE9UMEVhbENaQTZPakF5VmdPTm9QU0J1YnJ4VEF4MXoxMExGbXYzUUp5Y2diRlFPbzgxOVhNUm50c0xRWTN6YVN4dXAxYk5XS21vV2NWbTNYRQ?oc=5" target="_blank">FDA approves extended dosing intervals up to 20 weeks for EYLEA HD in wAMD and DME</a>  <font color="#6f6f6f">Ophthalmology Times</font>

Read Full StoryMore like this
Extended-Interval Immunotherapy in Advanced Lung Cancer: A Case Report
Cureusworld

Extended-Interval Immunotherapy in Advanced Lung Cancer: A Case Report

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPaThxTE9VbnlxOU1ESmRYWWJLYnFkdmpfTnYtczlMN1UtcUpaYVQtWGJzdXNwZUdWWVZYdUFYQWt3LTBIS2FQSHVuSWhiYVlqSGI5Q3A3VmpPeVJCZmVCREtHTjhzcFFIckxqaXAwM2VnYi1ZMk1nUjFYdzRXRE4wUkt1aHJCMzZ0bThjMzl4eEg2NENOTW5xWUQ1WE83dnR1NFlPaWhjMlVjWExR?oc=5" target="_blank">Extended-Interval Immunotherapy in Advanced Lung Cancer: A Case Report</a>  <font color="#6f6f6f">Cureus</font>

Read Full StoryMore like this
Feasibility of a 50% Dosing Interval Extension of Anti–IL-5 Biologic | JAA
Dove Medical Press Ltdgeneral

Feasibility of a 50% Dosing Interval Extension of Anti–IL-5 Biologic | JAA

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOSldOQlpwYS1UVFRkNDktOE5SVDJRbkRYUU51dks2YkFpZURlVEtPdnUzajVndXpjWUVBNVRXdGFlOG40T3FSWmZsYkg1Wk9yQkI2Q1BtRE9QRmtwM3h2N0g2cFRVcW1pNzZtUi0ya2wydVM1dU9zVzRnUzFjemJRbks3R0toa3MxWDM0OW4ycVpfUmkwUUR1WHljWGZQV1ppM2FJMTl0bEF2ek1tblhLM3pDaTF0NjNQNmNLSFFTeWdQX0w1RUVvdHhLZw?oc=5" target="_blank">Feasibility of a 50% Dosing Interval Extension of Anti–IL-5 Biologic | JAA</a>  <font color="#6f6f6f">Dove Medical Press Ltd</font>

Read Full StoryMore like this
FDA Approves Extended Eylea HD Dosing Interval for wAMD, DME - MPR
Medical Professionals Referencegeneral

FDA Approves Extended Eylea HD Dosing Interval for wAMD, DME - MPR

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxPYV9ZUUdZSTVYYUZveDJsMUY4N3B4aF96ZWNYNGNUMVVOZlh1eVVxYUlCdThzSFI2VGd6WC1kNHQyVFM3X2g1R1c5aHAtcHBBOEF5c0FhX1BCWTFnVGNHUEZ0VkF5WEVVN2N1ZWxwaEplYmZOWTBqNGhHcTNFbW80MTN5ay1aeDM3SDVwTmc0RQ?oc=5" target="_blank">FDA Approves Extended Eylea HD Dosing Interval for wAMD, DME - MPR</a>  <font color="#6f6f6f">Medical Professionals Reference</font>

Read Full StoryMore like this
Study Supports Use of Annual Rituximab Maintenance Dose After Multiple Sclerosis Remission
Neurology Todaytech

Study Supports Use of Annual Rituximab Maintenance Dose After Multiple Sclerosis Remission

<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE5BNGJoUEMtRHNDWXVhLVUyZXQ3dnZ2NFN6UmdxZjV6azVsSlFoOWVrTGpWY0pDbHNUNEhCMXhwY3k0RUVabll0bEVHakpONE9mYjlIRGJnSjdpU0x6ck9UU29oeFVYTEtRZFpMUG1DMXJ3TjdKXzV0NA?oc=5" target="_blank">Study Supports Use of Annual Rituximab Maintenance Dose After Multiple Sclerosis Remission</a>  <font color="#6f6f6f">Neurology Today</font>

Read Full StoryMore like this
FDA approves expanded EYLEA HD dosing intervals
Glance by Eyes On Eyecaregeneral

FDA approves expanded EYLEA HD dosing intervals

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPcTFpRlFueTUyUDlNTFhRT2NUYlNHdHo4a000ejZlWDVSdGg0UlpSUkIwWG9mYTJiVVd1S0dmWTk4dFh5UHEzd3NJejN6dzVjSGNONkVpMmNHNExONjhrMGZVRnZNZVZndmJ6cWx2ZzJ2Z0VDV0tuNzRUTENfZktSTHFvT1pZbl81eDliMEhNR1p2R2t3VnpmYTlRdEdaLUdEUFE?oc=5" target="_blank">FDA approves expanded EYLEA HD dosing intervals</a>  <font color="#6f6f6f">Glance by Eyes On Eyecare</font>

Read Full StoryMore like this
Regeneron Wins FDA Nod for Extended Eylea HD Dosing Interval
Yahoo Financegeneral

Regeneron Wins FDA Nod for Extended Eylea HD Dosing Interval

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNUHZoTVd3VlBLSS1rX0xUQmhNYXdsZEMzMHdMZVUyMTZxOWNsVFlJV1lzMkI4WXE4VDV3QUZyQ0Y0X3FvenRyNnJGdFd1N2FHVzk3REtlQ2JyRVd6U0E2ekMtRVFPOFBzeFIzYmhPN3VCQXAzMmRUSkV3SlhLSXpBNkdoaHByaGo2LVpmZTdnS2JDelR1cVQ2RHVucHVOV2pXdXc?oc=5" target="_blank">Regeneron Wins FDA Nod for Extended Eylea HD Dosing Interval</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Natalizumab-Associated Progressive Multifocal Leukoencephalopathy After Natalizumab Extended Interval Dosing Therapy in Japan
Neurology® Journalsgeneral

Natalizumab-Associated Progressive Multifocal Leukoencephalopathy After Natalizumab Extended Interval Dosing Therapy in Japan

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBHcWczR09rN1ZRQ3g1XzV4dE4xYTlNUWVvMmZiUTJhOGJxc0UyTm5nd3ZCeXIwaWlMTWJpVXNmSGliam56QzI4STZNU2l2ZWlod01GUzE4RmpTRXVWaTZVaVZ2RVk1T2lUNGc?oc=5" target="_blank">Natalizumab-Associated Progressive Multifocal Leukoencephalopathy After Natalizumab Extended Interval Dosing Therapy in Japan</a>  <font color="#6f6f6f">Neurology® Journals</font>

Read Full StoryMore like this
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
BioPharm Internationalgeneral

Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQOTkySjROSFcxVmI4M3dWUGpRT0M2VVlwSEIyQ2xYbVFWNmIwbWZNd0RidGphc2VlSEhmUExEWXFuUDkteFR6SF9jNjQwY1pONmFxbVlhSlQ5eGx3aUhZNGdUZDBGM0xMNWFPcWNWVnl5bHFhb1NGWWlpTW1LcXFDTUh4emM2dDJmV0M1cGkxbmVVVnVGZDh3ZHZETlpMN3M3WmItSjFCQlU?oc=5" target="_blank">Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity</a>  <font color="#6f6f6f">BioPharm International</font>

Read Full StoryMore like this
Monthly Enjaymo dosing keeps refractory CAD under control
Cold Agglutinin Disease Newsworld

Monthly Enjaymo dosing keeps refractory CAD under control

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNYm5YejNiaWdhVVVJU3JLY29CZHk2dGx5ZXk5VkNlc3NWZHNYMDhGeUpBRHZMWW1ubTk3SlBmMzBBaWw2TC04S1Q3M2VNZFN0eTRUWXVZMk1keXlQTmlCczhKNy05NWxkcUlmcmpjOUxfaVp4dWMxUURBMm5LczhZRF9lZFB0MUJCM2lheGpWaWxfcWx3d1dKdEJR?oc=5" target="_blank">Monthly Enjaymo dosing keeps refractory CAD under control</a>  <font color="#6f6f6f">Cold Agglutinin Disease News</font>

Read Full StoryMore like this
nAMD: Aflibercept 8 mg sustains extended dosing intervals through 96 weeks in most patients
Vera Healthtech

nAMD: Aflibercept 8 mg sustains extended dosing intervals through 96 weeks in most patients

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPWDYtMDBiRTQtRHUtcy1BTEtyX0ZWZHN3QkNPMXA3eWd1bW1lU1pZdElkQ3MwSU94R0hXdThFNGprbFdfRkRmX3BQTU1FTkZHeXpRbU9OWWU1Um1PMTlBMlR0cGNkZndmMWQwTUViam5QbVAzMmRrdC1vcTUzUDExS19tanJ3S0k4UXQwa2hwUkVybFJtTW05VTRPRWpXSHFEQ3phWjJfZi1ycWhsa0ZZ?oc=5" target="_blank">nAMD: Aflibercept 8 mg sustains extended dosing intervals through 96 weeks in most patients</a>  <font color="#6f6f6f">Vera Health</font>

Read Full StoryMore like this
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
Springer Nature Linkgeneral

Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE82bDdwNWVLeGJaRjI4QVF3bUR3WVEtQTJXRWk5Q0pVdnRqTXBhZWxmTmdvOFR0X1hIQ2RFSFdHRzRWdmM3MXFBck9UeE5raUs4N1ZWblpjbEVKZ3haYzd5S1BRYlBaZktuTVVJVw?oc=5" target="_blank">Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials</a>  <font color="#6f6f6f">Springer Nature Link</font>

Read Full StoryMore like this
Could Twice Yearly Dosing Be Enough? Zumilokibart Data Raise the Bar for AD
Dermatology Timestech

Could Twice Yearly Dosing Be Enough? Zumilokibart Data Raise the Bar for AD

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxPaEhMV1lWTXBXMkd6bGNsTV9DRldwaXNHZlgxb0tJa2xMS0FpMVdDekFTV240aEtIYkhoOHI0Q1dLdEQxZjdVeW5CblRqUWxTWFl0bE1aSFdlYk5QSkhWb0RKWHRISnFFRU1mU3hXMzI0ZVdROWhLR3BzN2gtc3RMUnY0WWdvMDFfT1RQbDdQN3ZyX1BxTjVWUlh3QXpKVzBFRXpKS2hHQzF4UC1LTFRhb2V3?oc=5" target="_blank">Could Twice Yearly Dosing Be Enough? Zumilokibart Data Raise the Bar for AD</a>  <font color="#6f6f6f">Dermatology Times</font>

Read Full StoryMore like this
Extended Interval Dosing of Anti-CD20 Therapies: Balancing Efficacy and Safety
NeurologyLivegeneral

Extended Interval Dosing of Anti-CD20 Therapies: Balancing Efficacy and Safety

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQR1JjUFZIa21hSmdPR0NsckRicGN6cURfZG9fS1lyNW1qVVdGM3BDVVU4ZHdYUlY3SzJkMnprR0N4aEFrcWl2bUhpNWNhTWRqOVdac0J6ZEpBMFdqR0haWXA1Tk00WmVocVY5eThmOHhkbzhPQ1dIMTVjMENOWVJacDZVaXhtcno2UHJSSXp2X2JXSWVFVDJuZ3libWkzS1B1azNLc1ZYZHVHQktTeXZuU0hn?oc=5" target="_blank">Extended Interval Dosing of Anti-CD20 Therapies: Balancing Efficacy and Safety</a>  <font color="#6f6f6f">NeurologyLive</font>

Read Full StoryMore like this
Extended-Interval vs Standard-Interval Dosing of Single-Agent Pembrolizumab
The ASCO Postgeneral

Extended-Interval vs Standard-Interval Dosing of Single-Agent Pembrolizumab

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNdjZqeS1wSlptcVItTWtKa0k3QkJTc1ZGVWtVZTNoUWlSc3JvdzFXWDNka3lqZUJCX01wQTNpVkx0a1dEc2dqUno3UTYycnNYLVFodkpxZkxycUhuOWtQS0pGcWZaZTdvcllYZnpLb3J0R05SNVBjUmVHWkFwWmZDRDBwWXNlYkFHUjRER2RBRHE5dXpEY0VQVlEwOEt0MlBzd0pVak95REVpRHVvUGhvSnUyRTh0UQ?oc=5" target="_blank">Extended-Interval vs Standard-Interval Dosing of Single-Agent Pembrolizumab</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
BioPharm Internationalgeneral

GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNeFBnczVISDRVNzhZTWVoUVJ4ekVJdlhkelFtWW03YnlxbW9GUGZ2TEI3bHpXSERwdjFJQUJQcHh4TWJVM3ZJWnhXMlYwcVhPdTk4TkZFb3pIWVBDYWFVUFJCMUE4Rm5mV0hjQ3k0ZmRNMUhSbXVZLU9NdHRMNVRfaHNSRHAyRE1GLVdkZ1laUzNJN1g5WTE1M282b0JXdzJnTTdVVFRzRW8xQXRnSHV1dmViaVpWRTFSNWc?oc=5" target="_blank">GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies</a>  <font color="#6f6f6f">BioPharm International</font>

Read Full StoryMore like this
ViiV Healthcare shared pipeline and real-world data | CROI 2026
Managed Healthcare Executivescience

ViiV Healthcare shared pipeline and real-world data | CROI 2026

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOcUptUDZCdXZxa2RhbkdRX2E2RTJNcjlnSEdPeTZCRjJYdkFELXFmYkUwQy1HNkNuZDVxQ0pxdWNTcEE1TXJwT2tjQkZqbk11a2gwVUw5dmZWeThuSXA2ekZRbHZGRHZMaGJTZm02MnhEbmRzSGU0MHNlZzJoSlpwNWc2V0tlS1VmZ05HcE1QTFl3VXNfa0VWT0w4Y0pQWEhvWVp3UXdabWZVLVU2b0ptN3JVNjM?oc=5" target="_blank">ViiV Healthcare shared pipeline and real-world data | CROI 2026</a>  <font color="#6f6f6f">Managed Healthcare Executive</font>

Read Full StoryMore like this
In MS, less frequent treatment dosing schedule is equally effective
Multiple Sclerosis News Todaygeneral

In MS, less frequent treatment dosing schedule is equally effective

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxOTmFsajJ1Y2ozb1l6ejhka1lfOGJBS29nZXpoY19QOG5SQ09DVjc0a09oOUlFbE1SZDczU2Z4Z3VuaXpjTzB3bUo3dzItS1dMTE1UMTctUWkwaHc2RnlKYWRkUnhSa29TRG9qOWk3dFhqWnNrajRLSEpZdjFrRUxiRHBURlJIUXBJUk9IbUg4OWRTWGIyRjhWMk1OTE5sS3ltQzBLSEdNbVJBTXZ5M09yTkpOdlMzXzloSWVwMjk1d0FyaTd2UkdTUWhPUjFsVFNCLV9IaA?oc=5" target="_blank">In MS, less frequent treatment dosing schedule is equally effective</a>  <font color="#6f6f6f">Multiple Sclerosis News Today</font>

Read Full StoryMore like this
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients
Natureworld

Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE15NDFvbmYxY0RTR1ZPNXVTdEhtN0Rzb1lKa3paT1F4NF9MeXk0TDRsd0xqa29yVFpfSnNiV3JJMXdoSHd3Z3h3TGtZY2I4UDgwdW1PczdycjlUVnNoMEVV?oc=5" target="_blank">Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Extended Interval Dosing of ICIs Does Not Increase Immune-Related AEs
Cancer Therapy Advisorworld

Extended Interval Dosing of ICIs Does Not Increase Immune-Related AEs

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPQkhMMGlnSDVyZXFWUXpMLV9RVGNldU8xSjRTcVZLdWJHMTF6S3dTUDF4MHZhVkVtb0hGRXZRaUxsdEFMTlJhTmV2emp2bkt6RWp0VVI3VFQ5WDNGSWE0NEs3VjBaUnNXYlZTX3lRTl85RmRDVkRLSGF5YlBCNnlBNUxDT0xkbWNDclNJRjBkQkdfdko3WG1GTGFMa3FEVjZJQ19HdEhsTXNtQTJseTVpMGtEel81V0l0TEE?oc=5" target="_blank">Extended Interval Dosing of ICIs Does Not Increase Immune-Related AEs</a>  <font color="#6f6f6f">Cancer Therapy Advisor</font>

Read Full StoryMore like this
Natalizumab extended-interval dosing in a real-life setting.
Physician's Weeklygeneral

Natalizumab extended-interval dosing in a real-life setting.

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQNUJzY0ozWGlaRHNVeUpaSUNNZjhzb2wwLVQwb2UtMTJUMEJOeUpCTzVrVy1BZjEyRkpQWE03TDdLV0VGVEl6VGlKMkZZSlhocTFBcVNrcVZibldXY21oUExucXpheGZVeV9ZTG5FWHB2c3JLWHdwbkpmd1hnS2NQTFpGczM0UG5yd0h5VlBKX3lVZTlpWlR0Tkt6TFI4OWs?oc=5" target="_blank">Natalizumab extended-interval dosing in a real-life setting.</a>  <font color="#6f6f6f">Physician's Weekly</font>

Read Full StoryMore like this
[Interview] 'Eylea 8mg emerges as only nAMD therapy enabling 20-week dosing interval'
Korea Biomedical Reviewgeneral

[Interview] 'Eylea 8mg emerges as only nAMD therapy enabling 20-week dosing interval'

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBiVVhPWi1GU2RmMUgtVklFd1phYXA2MG45Q29FeVNETmlzWUpiSXNHQWxuX21wSmN3ZnRfYVoyN3E3aVhiMlFFT2dPNzlCcmlJSjJpRVFzdmhwTW1hajZJaUI4dkhXSXRvQnZadm5R0gFyQVVfeXFMTVp3R3drU3JfQjE4QWlGa2gxaUVYNUVDWjJmYTRtUkdsbGFObU5ScEEtSUxCNlAtaHYxYUxPZ0hwYTUwVnFBS2VZWXdqSWZTQkRWVk9yOTRnRTNjZmZsdjRMREVQY3cwZGotekR5bUY3aEdn?oc=5" target="_blank">[Interview] 'Eylea 8mg emerges as only nAMD therapy enabling 20-week dosing interval'</a>  <font color="#6f6f6f">Korea Biomedical Review</font>

Read Full StoryMore like this
Extended dosing of Tysabri is effective RRMS treatment: NEXT-MS
Multiple Sclerosis News Todaygeneral

Extended dosing of Tysabri is effective RRMS treatment: NEXT-MS

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOUVNlTl94NjA2TFFKMEtiTUNycHI0ckluZkR1LVpLdWpwMjYyMUZlQklOYWlDNGIyQTU0S08yN05Gb1F4T29ZVDI3UUJBUXRFOWlfa0lLdHkwUHBrT1ppeklTZ0ctMVlKNHVnNDNXSTZCNTdaUkFWb3l1bm9fWk1QOV9UVUlqYmZqdXZwaDFQaEZDLV9uYWJHY1FWVG4zZm5INjc5dk5tWFQ1WFZrbGNDX3Q3aXZZNDA?oc=5" target="_blank">Extended dosing of Tysabri is effective RRMS treatment: NEXT-MS</a>  <font color="#6f6f6f">Multiple Sclerosis News Today</font>

Read Full StoryMore like this
Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study
Frontiersgeneral

Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOU1JBYVVZYzJEWXFwNDJFQWtOQjh5NG96dWZzcmZkaFZDZzN0ZE1XNlJRd01fV1otUlpFX1FBOU00c3pMb3NRMWZzVXJPd1c0bmR5cFo1NkxQbFRjM2dYbDdfSjdINkhsSmFOWDlObHpfN1ZGaTVqM2NPcWlqUzhmNTZmRzV2cGttY3FZX1JDOWI?oc=5" target="_blank">Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
"Extended Interval Dosing" — Live Google News Trends & Headlines